Reduction of Tumor Biomarkers from very High to Normal and Extensive Metastatic Lesions to Undetectability in a Patient With Stage IV HER2-positive Breast Cancer Treated With Low-dose Trastuzumab Deruxtecan in Combination With Oral Recombinant Methioninase and a Low-methionine Diet
Anticancer Research · 2024
DOI: 10.21873/anticanres.16946 ↗Kurz gefasst
Fallbericht in der Zeitschrift Anticancer Research, 2024. Verfasst von Motokazu Sato und 9 weiteren Autor:innen. Beteiligte Einrichtung: AntiCancer Inc., San Diego, CA, U.S.A. Hauptthemen laut MEDLINE: Breast Neoplasms, Immunoconjugates, Carbon-Sulfur Lyases. Die Arbeit wurde bisher 11-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- AntiCancer Inc., San Diego, CA, U.S.A.
- Department of Surgery, University of California, San Diego, CA, U.S.A.
- Department of Oncology, Yokohama City University School of Medicine, Yokohama, Japan.
- Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, Yokohama, Japan.
- AntiCancer Inc., San Diego, CA, U.S.A.; all@anticancer.com.
Zitieren
APA
Sato, M., Han, Q., Mori, R., Mizuta, K., Kang, B. M., Morinaga, S., Kobayashi, N., Ichikawa, Y., Nakajima, A., & Hoffman, R. M. (2024). Reduction of Tumor Biomarkers from very High to Normal and Extensive Metastatic Lesions to Undetectability in a Patient With Stage IV HER2-positive Breast Cancer Treated With Low-dose Trastuzumab Deruxtecan in Combination With Oral Recombinant Methioninase and a Low-methionine Diet. Anticancer Research. https://doi.org/10.21873/anticanres.16946
Vancouver
Sato M, Han Q, Mori R, Mizuta K, Kang BM, Morinaga S, et al. Reduction of Tumor Biomarkers from very High to Normal and Extensive Metastatic Lesions to Undetectability in a Patient With Stage IV HER2-positive Breast Cancer Treated With Low-dose Trastuzumab Deruxtecan in Combination With Oral Recombinant Methioninase and a Low-methionine Diet. Anticancer Research. 2024. doi:10.21873/anticanres.16946
BibTeX
@article{Sato2024,
author = {Sato, Motokazu and Han, Qinghong and Mori, Ryosuke and Mizuta, Kohei and Kang, Byung Mo and Morinaga, Sei and Kobayashi, Noritoshi and Ichikawa, Yasushi and Nakajima, Atsushi and Hoffman, Robert M},
title = {Reduction of Tumor Biomarkers from very High to Normal and Extensive Metastatic Lesions to Undetectability in a Patient With Stage IV HER2-positive Breast Cancer Treated With Low-dose Trastuzumab Deruxtecan in Combination With Oral Recombinant Methioninase and a Low-methionine Diet},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.16946}
}
EUVIMED